Pernix Therapeutics Holdings (NYSE:PTX) major shareholder James Edward Jr. Smith sold 45,000 shares of the stock on the open market in a transaction dated Tuesday, May 6th. The stock was sold at an average price of $4.44, for a total transaction of $199,800.00. Following the transaction, the insider now directly owns 4,337,704 shares in the company, valued at approximately $19,259,406. Pernix Therapeutics Holdings Inc. (NASDAQ:PTX) net profit margin is -30.20% and weekly performance is 5.52%. On last trading day company shares ended up $4.78. Analysts mean target price for the company is $4.43. Pernix Therapeutics Holdings Inc. (NASDAQ:PTX) distance from 50-day simple moving average (SMA50) is 3.47%.
Omega Protein Corp. (NYSE:OME) VP Gregory P. Toups sold 5,000 shares of the stock on the open market in a transaction that occurred on Thursday, May 8th. The shares were sold at an average price of $13.37, for a total value of $66,850.00. Following the transaction, the vice president now directly owns 30,378 shares of the company’s stock, valued at approximately $406,154. Omega Protein Corporation (NYSE:OME) shares advanced 1.27% in last trading session and ended the day on $13.51. OME gross Margin is 33.90% and its return on assets is 10.40%.Omega Protein Corporation (NYSE:OME) quarterly performance is 26.14%.
Carbonite (NASDAQ:CARB) EVP Swami Kumaresan unloaded 77,972 shares of the stock in a transaction that occurred on Wednesday, May 7th. The shares were sold at an average price of $10.28, for a total value of $801,552.16. Following the sale, the executive vice president now directly owns 33,970 shares in the company, valued at approximately $349,212. Carbonite Inc. (NASDAQ:CARB) shares moved up 4.83% in last trading session and was closed at $10.41, while trading in range of $9.91 – $10.45. Carbonite Inc. (NASDAQ:CARB) year to date (YTD) performance is -12.00%.
BioTime (NYSE:BTX) Director Broadwood Partners Lp acquired 300,000 shares of the company’s stock in a transaction that occurred on Thursday, May 8th. The shares were purchased at an average price of $2.44 per share, for a total transaction of $732,000.00. BioTime, Inc. (NYSEMKT:BTX) ended the last trading day at $2.35. Company weekly volatility is calculated as 9.53% and price to cash ratio as 29.75.BioTime, Inc. (NYSEMKT:BTX) showed a negative weekly performance of -3.29%.